Toxicology Letters

Article	Citations
S05-03 The development of a human liver-based In Vitro test battery to detect liver steatotic potential of chemicals from various applicability domains	66
P02-46 Cultivation conditions in microfluidic environments: insights from 2D and 3D cell culture models	55
P01-39 Mitochondrial toxicity screening to support the R&D crop protection pipeline	40
P07-09 Spatio-temporal multi-omics analysis of lung tissue and matched biofluids identifies circulatory safety biomarkers for monitoring inhaled drug induced lung injury	39
P02-47 A rat in vitro 3D airway model for translational toxicology	38
S20-04 Generic pharmacokinetic models for mother-to-offspring transfer of environmental chemicals	36
P09-10 The synthetic cannabinoid ADB-FUBINACA disrupts mitochondrial biogenesis of NG108-15 neuroblastoma cells during neuronal differentiation at human-relevant concentrations	33
P12-13 Role of endoplasmic reticulum stress in sunitinib-induced hepatotoxicity	30
P02-26 Optimized iPSC-derived hepatocytes offer a novel liver cell model for in vitro predictive toxicity and drug efficacy studies	29
P08-03 Comprehensive digital documentation and computer-assisted evaluation of the skeleton of Alizarin Red and Alcian Bluestained rat foetuses	27
P17-07 Prenatal exposure to acrylamide and metabolic status at 20 years of age: a prospective biomarker-based cohort study from Denmark	26
The toxicology of inhaled nanomaterials and examples of risk assessment and regulation	25
P21-54 Searching for links in binding patterns among androgen and progesterone receptor ligands	25
P19-50 In-chemico reactivity methods based on molecular initiating event of skin sensitization: refinements and possible application to cosmetic formulations	25
P07-18 Acute phase proteins in Göttingen minipigs: comparison between haptoglobin, Pig-MAPP and CRP in the context of a vaccine study	25
P07-05 Miniaturization of haematology sampling in rodents on toxicology studies	25
P14-06 The cytotoxicity of bortezomib in AC16 cardiac cells and possible therapeutic options involving Nrf2	23
P02-22 Establishment of a microfluidic neurotoxicity screening model using human iPSCs-differentiated motor neurons within the New Approach Methodologies for chemical safety developed for Precision To	22
P13-36 In silico analysis of positive and negative effects of isothiocyanates in breast cancer	22
P19-03 Integration of transcriptomics data for ED assessments using an Adverse Outcome Pathway Network approach	22
P08-10 Advancing the use of New Approach Methodologies for assessing teratogenicity using a tiered approach: metabolism consideration to improve the human relevance	22
S23-02 Assessment and modelling of metabolites: the conazole case study	21
P20-27 Zinc suphide – considerations and challenges for acute inhalation toxicity testing and classification under REACH	21
LP-10 Comparative analysis of occupational exposure limits (OELs) for inhibiting RNA therapeutics	21
P06-04 Advancing bladder cancer detection: unveiling a novel urinary biomarker panel through metabolomics	21

Toxicokinetic relationship between the adducts in globin and their cleavage products in the urine: Implications for human biomonitoring	21
P17-36: Ti-alloy (TiAl6Nb7) metal powder toxicity in human embryonic kidney (HEK-293T) cell line	20
LP-17: Evaluation of Genistein as a Mitochondrial Modulator and its Effects on Sperm Motility	19
P09-34: Unraveling hormonal dependencies and associated species-specificities of neurodevelopmental key events to improve EDC risk assessment	18
P22-02: The Renal Proximal Tubule TXG-MAPr: Safety Assessment Based On Quantitative Gene Network Analysis	18
P19-05: Comparison of in vitro and in vivo study results for classification of plant protection products	18
P23-05: Urinary monohydroxyl-polycyclic aromatic hydrocarbons and metals in firefighters with active participation in controlled structure fires	18
OS03-10: Predictive Modeling of Deltamethrin Exposure in Fetal Brain Tissue: Implications for Human Health Risk Assessment	18
KL02 | EUROTOX Lecture Award	18
S12A-03: Occupational exposure to copper in dust: Chemical characterization and impact on regulation	17
P10-09: Toxicological aspects of the Horizon EDIAQI project	17
P25-13: Polo-like kinase 4 (PLK4) Safety Review – distilling the risks with a rapid augmented intelligence approach	17
P09-46: Preliminary results of the second National Human Biomonitoring program in Slovenia: bisphenols, parabens, PFAS, glyphosate and trace elements in children and adolescents	17
P22-35: Mapping of DNT NAMs’ signaling pathways in human physiology and disease for regulatory application	17
P19-07 Dermal occupational exposure assessment – comparison of selected modeling tools	16
P22-31: Training the next-generation toxicologists	16
P08-21 Lack of genotoxicity of Rhamnus Purshiana, Sennae Fructus, and Rhamnus Frangula in a micronucleus assay in vitro (OECD 787)	16
P13-07: High-dimensional profiling of immune response to vaccines using bio-stabilized and injectable natural human skin	16
S09-03: NAMs in DART testing of pharmaceuticals under ICHS5(R3)	16
P08-15 Assessing of in vitro genotoxicity testing strategy for T-2 mycotoxin	15
LP-40: Non-clinical Safety profile of a new i.v. Formulation of Rifabutin (BV100) – an Opportunity for new Treatments	15
P08-18 Predicting non-genotoxic carcinogenic potential of agrochemicals: a mechanistic approach	15
P03-03 Autopsy findings and toxicological results in Khat-related fatalities in Jazan, Saudi Arabia	15
P19-08 New values of occupational exposure limits (OELs) of inhalation anesthetics: enflurane, isoflurane, sevoflurane and desflurane in Poland	15
P17-26 Assessment of anabolic steroids impact on 5β-reductase by virtual screening and in vitro approaches	15
SOC-I-06 Differentially expressed microRNAs in human bronchial epithelial cells after exposure to nanofibrillar, microfibrillar or nanocrystalline cellulose	15
P13-07 Addition of physiologically relevant conditions has the potential to effect the toxicology of engineered nanomaterial hazards in an in vitro co-culture of the alveolar region of the lung	15
P06-22 Reproductive and developmental toxicity testing of a complex UVCB: implications of current dose setting advice under REACH for generating meaningful study outcomes	14
P16-05 Influence of the new potential antidepressant SMe1EC2M3 treatment on neuronal outgrowth and arborization	14
S11-01: A regulatory perspective: hazard identification and potency classification	14
P21-17 Risk assessment of chemicals in the Dutch red meat production chain	14
Reviewers	14
P05-06 Protective role of peroxiredoxin V against UVB-induced apoptosis of epidermal keratinocytes	14
CEC07-03 Towards internal threshold of toxicological concern (iTTC): Implementation of Pharmacokinetics (PK) in the safety assessment	14
P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications	14
P08-08 Toxicogenic effects of leaf extracts from an Andean medicinal plant	13
P22-17 Acrylamide exposure estimates in the EuroMix biomonitoring study using a probabilistic approach	13
S-29-02 Assessing the risk of mitochondrially active compounds in medicines development	13
S-03-02 Development of T2 MRI biomarker of neurotoxicity as a noninvasive quantitative approach	13
P04-19 Selecting drug like structures using in silico tools	13
P21-31 Criteria for selecting physiologically-based kinetic models for use in developing new models for data-poor analogues via a read-across approach	13
S-17-02 Prioritization of contaminants for evaluation in food by WHO/FAO expert committees	13
P14-04 Compartmental toxicokinetic model for urinary excretion of cleavage products resulting from adducts with globin	13
P16-01 Silver nanoparticles suppressed retinoic acid-induced neuronal differentiation in SH-SY5Y cells	13
P22-16: Heated tobacco and e-vapour products induce lower biological activity compared to cigarettes using the ToxProfiler assay	12
S-01-03 Integrating in vitro distribution kinetics analysis in IVIVE-PBK	12
P22-24 Polystyrene nanoplastics induced cognitive impairment through dysregulation of autophagy and synaptic plasticity in rats	12
S04-03 Sponsor Perspectives on Implementing WOE Approaches	12
LP-46: Counterfeit drugs awareness among a Mexican sample: An underappreciated health risk	12
PL04-01 Challenges and opportunities for regulatory toxicology under the chemicals strategy for sustainability	12

S13-02 NAMs to investigate chemical-induced immunotoxicity: the cases of PFAS and BPA analogs	12
LP-27: Combination of air- and biomonitoring to control cadmium exposure at the workplace	12
P17-27: Role of oxidative stress in microplastic polymethyl methacrylate (PMMA)-induced hepatotoxicity with HepG2/THP-1 co-culture model	12
P33-06 Disruption of the plasma membrane organization and neuroinflammation can be triggered by toxic organophosphorus compounds	12
P14-07 Outcome of the re-assessment of the risks to public health related to the genotoxicity of styrene present in plastic food contact materials	11
S27-03 The microbiome modifies neurobehavior in zebrafish exposed to Aryl Hydrocarbon Receptor (AHR) modulators	11
P09-14 Health Impact of PM2.5 on Pregnant women and Children: Systematic Review	11
P28-20 Challenges and Best Practices in Conducting Multigenerational Studies: A CRO Perspective	11
OS01-08 Activity-based characterization of New Psychoactive Substances (NPS): a forgotten technology with new forensic applications	11
P12-26 Effect of ketogenic diet on the metabolism of ozanimod in mice	11
S24-02 Studying and comparing the role of time in in vitroand in vivotoxicity tests	11
Are electric vehicles actually bad for the environment?	11
P09-33 Oxidative Potential of Traffic-Derived Ultrafine Particles and Their Impact on Olfactory Mucosa Cells in Alzheimer's Disease	11
P29-11 A delayed activation of p38 MAPK in dendritic cells distinguishes respiratory from skin sensitizers	11
P23-11 RVG-modified sEVs selectively delivers BDNF to brain, promotes neurogenesis and mitigates Parkinson-like symptoms	11
P07-07 Investigation of the Endocrine Disrupting Effects of Lilial	11
P09-11 The disruption of the human astrocytic cell cycle by hexavalent chromium	11
S02-01 Probabilistic Risk Assessment in Practice	11
P23-14 Heavy Metals: Toxicity and Renal Damage	10
P23-08 Importance of Buccal Micronucleus Assay in the Biomonitoring of DNA Damage in Paint Workers	10
Gentamicin administration leads to synaptic dysfunction in inner hair cells	10
A critical review of microplastics toxicity and potential adverse outcome pathway in human gastrointestinal tract following oral exposure	10
Comparative effects of e-cigarette and conventional cigarette smoke on in vitro bronchial epithelial cell responses	10
CEC04-05 Feasability of quality criteria and tentative assessment tools to align with artificial intelligence	10
Evaluating applicability domain of acute toxicity QSAR models for military and industrial chemical risk assessment	10
P24-11 Waiving of the dog studies in the regulatory process of agrochemicals approval	10
circ_0000554 promotes macrophage M2 polarization mediated by glycolytic reprogramming and aggravates COPD injury	10
Lysosomal membrane permeabilization mediated apoptosis involve in perphenazine-induced hepatotoxicity in vitro and in vivo	10
S13-04 Skin sensitization potency assessment: Make full use of NAM data to conduct quantitative risk assessment	10
P31-33 Classification based risk assessment in the safety evaluation of Extractables & Leachables	10
S08-02 Current and emerging concepts of cardiotoxicity: applicability inrisk assessment for regulatory purposes	10
Individual and mixed effects of PFAS on osteoporosis: Insights from epidemiological and bioinformatic approaches	10
Inhibition of placental 11β-HSD2 expression through cAMP/PKA signaling pathway induces intrauterine growth retardation	10
Evidence for adduction of biologic amines with reactive metabolite of 8-epidiosbulbin E acetate in vitro and in vivo	10
CEC04-02 Comparison of outdoor and indoor air pollution on cardio-pulmonary health	9
CEC01-01 Introduction into the AOP framework: Integrating Theory and Practice in AOP Development	9
OS02-03 Using a systems biology approach to construct adverse outcome pathway networks aligned with the FAIR principles	9
P02-30 Generation and evaluation of a historical control database for the creation of assay acceptance criteria for a comparative in vitro hepatic enzyme assay	9
Skin penetration and decontamination efficacy following in vitro human skin exposure to sulfur mustard	9
The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice	9
Copper exposure at a daily dose twice the recommended in diabetic rats induces oxidative stress, vascular dysfunction and perivascular adipose tissue inflammation in diabetic rats	9
Comparative toxicity of eleven bisphenol analogs in the nematode Caenorhabditis elegans	9
P01-62 Development of an in vitro model of dry nose	9
P17-03 Toxic and essential metals in breast milk: Preliminary results from Bosnia and Herzegovina	9
P26-02 Ensuring pharmaceutical packaging safety: an integrated approach for assessing extractable profiles and toxicological risk	9
P21-56 Shedding light on the epidermal alterations induced by blue light and heated tobacco products co-exposure: an in vitro study	9
In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay	9
The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl4-caused liver fibrosis	9
Exosomal miR-196b secreted from bronchial epithelial cells chronically exposed to low-dose PM2.5 promotes invasiveness of adjacent and lung cancer cells	9
BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice	9
A battery of assays for chasing ricin and its activity	9
Toxicity prediction using target, interactome, and pathway profiles as descriptors	9
S24-02 Biomarkers of neurodevelopmental effect can reduce uncertainty when assessing the risks of thyroid disrupting chemicals	9
P02-18 Using individual-centric model to detect immune-mediated idiosyncratic drug-induced liver injury at preclinical stage	9
P19-32 Advancing the application of New Approach Methodologies (NAMs) in systemic toxicity assessment of cosmetic ingredients: insights from cosmetics Europe long range science strategy (2016–2022) ca	9
Title Page	9
Enhancement of cigarette smoke extract-induced goblet cell metaplasia and hyperplasia exerted through IL-13 receptor α1 expression	9
Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats	9
The harmful acute effects of clomipramine in the rat liver: Impairments in mitochondrial bioenergetics	9
Advances in understanding the neurotoxicity of lead, cadmium, arsenic, and therapeutic strategies	9
P11-01 BPS and BPF by acting as mitochondrial disrupting chemicals cause changes in energy metabolism in human ovarian granulosa cells	9
P25-07 Do co-formulants influence PPP genotoxicity? – a case study	9
LP-22 In vitro Metabolite Profiling of CF3-Etomidate: A New Etomidate Analogs	8
CEC06-03: Documenting pesticide exposures from field studies: what is known and why we should know more	8
P23-03: Applying the Multiple Path Particle Dosimetry model for assessing Occupational Exposure to Active Pharmaceutical Ingredients	8
P04-06: Toxicity of particulate matter from experimental burning of domestic waste	8
P13-03 Comparative study of mutagenic/antimutagenic and genotoxic/antigenotoxic activities of ethanolic and aqueous extracts prepared from Arbutus unedo fruits	8
P23-11 Assessment of PAH exposure in trainee firefighters using a PAH CALUX bioassay	8
Endocrine disruptors and microplastics: facing complexity with connection	8
P09-18 Comprehensive search for genes that vary across three developmental neurotoxicants	8
Editorial Board	8
P01-02: An updated adverse outcome pathway network on chemical-induced liver steatosis	8
An integrated in vitro and in silico testing strategy applied to PFAS inhibition of antibody production to define a tolerable daily intake	8
S13-01: How far are we with the implementation of NGRA for cosmetics?	8
P01-63 The secretion of interleukin 18 by reconstructed human epidermis is a biomarker for in vitro prediction of skin photosensitization	8
P18-15 Determination of tramadol and its metabolite O-desmethyltramadol in blood and vitreous humor samples	8
S02-04 Computational Toxicology in Drug Safety	8
miR-520f-3p blocks MNNG-induced gastric precancerous lesions via the KLF7/NFκB pathway	8
P11-02: Online methods and tools for assessing chemical exposure in humans: a systematic scoping review for the ONTOX project	8
P26-11: Acute and subacute toxicity profiles in Sprague-Dawley (SD) rats treated with Piperis Longi Fructus (PLF) Powder	8

P01-04: Development of an Adverse Outcome Pathway (AOP) to assess the neurotoxicity of the exposure to benzo(a)pyrene	8
P06-40: Integrating physiologically-based pharmacokinetic modelling and 'omics data to derive a health-based guidance value for perfluorooctanoic acid	8
S12-06 Finding European research funding and writing a competitive research proposal	8
S23-04 RapidTox: decision-based workflow environment to advance human health assessment	8
P03-03 Quantitative in vitro to in vivo extrapolation (QIVIVE) for liver-induced thyroid toxicity risk assessment	8
P22-08: New strategies for the safety assessment of proteins in food/feed derived from biotechnology – the way forward	7
P10-03: Cadmium levels are related to clonal hematopoiesis and mortality	7
P17-30: Amorphous silica nanomaterials effects on human dendritic cells promote the T-cell response to the pneumallergen Bet v 1a	7
P08-12 The surfactant co-formulant POEA in the glyphosate-based herbicide RangerPro but not glyphosate alone causes necrosis and ER stress in mammalian cell lines	7
KL06 | Keynote Lecture	7
S-26-01 Methylmercury-induced modification of selenocysteine in selenoprotein P – Implication to its physiological function	7
LP-20 Halogen-free flame retardant is friendlier to the aquatic environment than PBDEs	7
P22-03: Read-Across case study – from hypothesis to regulatory acceptance	7
P16-21: Applications of an isogenic human iPSC-derived blood-brain barrier (BBB) model	7
P25-05: Media representation of Glyphosate in Slovenian Printed Media over 10 year period	7
P17-09: Polystyrene microplastics of varying sizes and shapes induce distinct redox and mitochondrial stress responses in a Caco-2 monolayer	7
P03-04 Validation of an analytical method to identify and quantify selected amphetamine-related drugs (ARDs) in whole blood (WB) using UPLC-qTOF-MS after extraction by MMSPE	7
P11-05 Toxic microelements levels in the blood clot of wild boar (Sus scrofa) for monitoring the contamination and biomarkers changes	7
P11-26 Exosomes derived from primed mesenchymal stem cells improve cell viability on an APAP-induced hepatic injury in vitro model	7
P12-08 Biological evaluation of pharmaceuticals inhibiting 11β-hydroxylase identified by virtual screening	7
CEC01-01: A hands-on introduction to applied artificial intelligence in toxicology	7
P10-25: Cytotoxic and genotoxic effects of particulate matter emitted in beauty salons	7
Editorial Board	7
P03-22: Sensitivity of primary human hepatocytes and HepG2 cells for genotoxicity testing of N-nitrosamines in the in vitro alkaline comet assay	7
P21-16 Cytotoxicity: regulatory definitions versus scientific knowledge	7
P17-12 Molecular network pathway analysis of arsenic and cisplatin in cancer	7
P22-05 Identification and hazard assessment of oligoesters, nonintentionally added substances present in food contact coating extracts	7
P22-27 Exposure assessment of total DON in urine of Portuguese adult population under the HBM4EU aligned studies	7
LP-04: Adverse Outcome Pathways of Toxicity-Induced Dry Eye: implication of ferroptosis and pyroptosis in corneal neuroepithelial entity	7
LP-23 Molecular glue degrader reproductive toxicity: what did we learn?	6
P22-11 Current challenges in water quality require advanced risk assessment	6
S-31-01 Setting the scene: human health impacts of micro- and nanoplastics (MNPs)	6
P17-13 Optimization of Macrophage Polarization and Phagocytosis Assays for Immunotoxicology Studies	6
P19-26 Assessment of hepatotoxicity induced by heat-not-burn cigarette extract using various types of hepatocytes	6
P08-15 Evaluation of nanoatrazine bioaccumulation in green microalga Raphidocelis subcapitata: characterization, stability and uptake analysis	6
P18-78 What does new nitrosamine data reveal about the CPCA framework?	6
P30-59 Interest of the Micronucleus test on Reconstructed Skin and skin organoids for cosmetic products	6
P22-46 Effects of plastic nanoparticles, paracetamol, ibuprofen and their mixtures on steroidogenesis in vitro	6
CEC01-03 The current biological understanding of the respiratory tract, the in vitro models available as well as their use	6
P18-62 Mechanistic Insights of BPA Alternatives on PPARγ Binding and Consequences on Adipocyte Differentiation	6
P17-04 Unveiling the Hidden Threat: Genotoxicity and Oxidative Stress Induced by Microplastics in Human Health and Immune Disorders	6
P04-16 In silico applications for the prediction and hazard assessment of transformation products originated from water disinfection treatment processes	6
LP-37 Biokinetics of fluorophore-conjugated microplastics in marine mussels	6
P10-12 Investigation of the effects of endocrine disruptors on T cells differentiation	6
S05-03 Shear forces affect cell differentiation and cell sensitivity in organs-on-chip models	6
P33-05 Preliminary Toxicological Evaluation of Four Candidate Radiosensitizers in Sprague-Dawley Rats	6
P22-02 Cytotoxic and genotoxic effects induced by aluminium oxide nanoparticles on TM3 Leydig cells	6
P31-18 Protective Effects of N-Acetylcysteine and Coenzyme Q10 Against Atorvastatin-Induced Myopathy and Oxidative Damage	6
P23-12 Updating Finnish biomonitoring reference values and health-based guidance values for occupational exposure and risk assessment of selected metals	6
S-05-02 How can grouping and read-across support safe(r)-by-design of nanomaterials and advanced materials? GRACIOUS	6
P20-14 The effect of non-functionalized polystyrene nanoparticles with varying diameters on human albumin (in vitro)	6
P17-21 Effects of early-life BPA analog exposure on natural killer cell function and development	6
P12-32 An all-human cell based tri-culture system distinguished through morphology, longevity, and functionality	6
P12-59 Assessing the placental transfer of dexamethasone via ex vivo human placenta perfusions: a step-up towards model informeddrug dosing in pregnancy	6
P16-17 The senescence-associated secretory phenotype (SASP) from colorectal cancer cells induce neurotoxicity: novel mechanism involvement of CD38-NAD+ pathways	6
P24-15 Targeted groundwater monitoring for plant protection products and their metabolites in agricultural regions of Slovenia	6
P18-64 Ring trial validation of a cell-based RAR transactivation method	6
P14-36 Development and optimization of flow cytometry driven analysis of micronucleus in vitro using 3D skin tissues	6
S17-02 OASIS Consortium: Strategies for detecting in vivohepatotoxicity with in vitro‘omic technologies	6
S16-03 Microbial pesticides: a regulatory overview	6
P21-12 Investigating the hematotoxic effects of the mixture of lead and polychlorinated-biphenyls by combining in vivo and in silico approach	6
P03-01 Harnessing the power of AI to drive organ-level toxicity predictions	6
P02-14 In vitro 2D and 3D kidney models to study the nephrotoxic response of uranium exposure	5
P10-18 Bayesian benchmark dose modelling of hypothalamic–pituitary–ovarian axis endpoints to assess DEHP exposure effects in female mice	5
P18-89 Bridging Physiological Accuracy and Worldwide Reproducibility: The EpiVaginal™ Model Integrated with Simulated Vaginal Fluid (SVF)	5
P31-05 Monitoring ototoxicity in drug development: robust in vitro & ex vivo models	5
P14-23 Toxic metal levels in cancer patients. Is the cell barrier leaking?	5
P29-16 Interspecies Comparison of Inhalation Toxicity of PA-6 Particles: Insights from Transcriptomics in In vivo Rat Studies and In vitro Human Alveolar Models	5
P09-12 Thyroid hormones concentrations in cerebellum, cortex and whole-brain rat samples at certain life stages	5
P05-13 Refining the high potency category rules to enhance the accuracy of exposure-based waiving arguments within a Next Generation Risk Assessment for skin sensitisation	5
P21-34 SARS-CoV-2 omicron infection aggravates lung fibrosis through IL6/ CSF/ RANTES activation and dysfunction of lipid metabolism in mice with PHMG-induced lung injury	5
Harmful beauty – Temporal profile of urinary phthalate metabolites in tattooed volunteers from Slovakia	5
P23-26 When Smoke Meets Dust: A Toxicological Study of Serum Heavy Metal Levels and Oxidative Stress Markers in Silicosis Patients	5
P28-22 Identification of candidate molecular markers for detection of abnormal Mullerian duct morphology in male Japanese quail embryos exposed to estrogenic substances	5
Spilled liquid mercury: Case studies, proposition of safety procedures with assessment of commercial cleanup kit and recommendations	5
P19-15 Hepatic Gene Expression Atlas of Acetaminophen-Induced Liver Injury: A Comparative Microarray Analysis in Humans, Mice, and Rats	5
P22-34 Synthesis and potential application in melanoma therapy of sodium carboxymethyl cellulose-coated iron oxide nanoparticles loaded with dacarbazine	5
P28-37 Juvenile hormone analog, fenoxycarb induced apoptotic effects in the developing ovary of Daphnia magna	5
P30-64 Exploring AOP-based linkages between Thyroid Hormone System Disruption (THSD) and Metabolic Adverse Outcomes	5
P18-105 Evaluation of Inhalation and Gastrointestinal Toxicity of Novel Benzoazepine Derivatives with Potential Therapeutic Effects for the Treatment of COVID-19 and Post-COVID Syndrome	5
P14-01 Age-related effects of AT1 receptor antagonist losartan on cognitive decline in spontaneously hypertensive rats	5
P01-58 Comparative mitochondrial changes caused by ionizing radiation in healthy and cancerous lung cells	5
P14-01 Initial cytogenotoxic screening of N-tosylindole, a new larvicide against Aedis aegypti, the transmitter of Dengue, Chicungunya and Zika	5
Binding of ligands to the aryl hydrocarbon receptor: An overview of methods	5
S23-01 The ASPIS-initiated Safety Profiling Algorithm (ASPA): setting the stage for Next-Generation Risk Assessment	5
P02-40 Novel in vitro protocol for evaluation of safety of intraoral medical devices	5
S21-03 CBD: a reprotoxicant proposed to be identified under CLP	5
P22-35 New methodologies for the hazard assessment of advanced nanomaterials: integration of mechanistic approaches in designed case studies	5
P24-07 Proposal for revision of default dermal absorption values in regulatory toxicology	5
P28-13 Evaluating embryo- and developmental toxicity of pyrethroids and its mixtures in human induced pluripotent stem cell-derived 3D cardiomyocytes	5
P27-10 Application of a quantitative approach to identify Poorly Soluble Particles	5
P21-28 Health risk contamination of Mercury in blood and meat after using autogenous vaccine against Streptococcus agalactiae in Nile Tilapia (Oreochromis Niloticus)	5
P14-04 The impact of short telomere length on cardiac disease	5
LP-37 Ciprofloxacin alters neuronal epigenetic patterns in vitro and in vivo at therapeutically relevant exposures	5
P05-31 PBK modelling concepts for a user friendly generic bovine kinetic modelling platform to predict transfer of compounds from feed, veterinary medicines and supplements to food	5